Abstract
Introduction
Localised breast tumours are typically managed by breast conserving surgery (BCS) combined with adjuvant radiotherapy, which provides comparable survival outcomes to traditional mastectomy [1, 2] , whilst providing a better cosmetic result. However, if histopathology of the resected specimen reveals tumour extending to the surgical margin, so called positive margin, then further resection is advised until a clear margin is obtained, since margin positivity is an important risk factor for recurrent disease [1] . Re-operation for positive tumour margin status can result in poor cosmetic outcome, increased patient anxiety, delayed adjuvant therapy and increased treatment costs [1, 2] . The frequency of positive margins following BCS varies depending on the health care setting, however, in the UK the reoperation rate is around 20% [3] .
Ultrasound or stereotactic guided wire insertion is frequently used in the pre-surgical localisation of small breast cancers prior to BCS. However localisation of a lesion using a guide wire will be inaccurate if the full extent of the disease is not identified by the imaging modality used to guide the wire insertion. Given its ease of access and low cost ultrasound is frequently utilised to direct wire insertion, yet the accuracy of ultrasound in delineating breast malignancies is known to be inferior to MRI [4] .
Conversely, while MR guided wire insertion might improve accuracy, it has limited availability, requires greater time and at increased cost. Recently, real-time MRI navigated ultrasound (rtMRnUS) has been introduced, that combines the benefits of both ultrasound and MRI. In this technique a previously acquired 3D MR dataset is co-registered to real-time US images. Both modalities are displayed simultaneously and the MR images can be used to navigate real-time US, allowing insertion of the guide wire into the optimum location.
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Two papers by Rizzatto [5] , Fausto [6] and co-workers explored the feasibility of coregistering MR and US images via an rtMRnUS technique in healthy volunteers and patients. The authors concluded that rtMRnUS is both accurate and reproducible. A number of authors have previously reported a superior detection rate for rtMRnUS than second look or targeted ultrasound in the detection of enhancing lesions previously identified on MR [7-10]. Chang et al. reported that rtMRnUS provided a more accurate estimation of breast tumour longest dimension than ultrasound alone when compared to histopathology results [11] .
The aim of this study was to evaluate the feasibility of utilising rtMRnUS in the surgical planning of BCS, via guide wire insertion, and to document initial clinical experience. Both lesion and global registration accuracy were assessed along with the number of failed rtMRnUS co-registrations.
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Materials and Methods
Participants
Ethic committee approval was obtained for this prospective study. Potential participants were prospectively approached regarding study participation if following triple assessment (mammography, ultrasound and biopsy) they had a biopsy proven malignancy and were scheduled for BCS. Exclusion criteria included normal contraindications to MRI and/or gadolinium based contrast agents. Following written informed consent, study participants underwent a supine contrast enhanced breast MRI examination prior to rtMRnUS guide wire insertion and subsequent BCS.
MR Imaging and Post Processing
Prior to imaging four MR visible external fiducial markers (vitamin E capsules) were placed in the 12-, 3-, 6-, and 9-o'clock positions relative to the nipple. If the lesion was located at an extreme edge of the breast, such as in the axillary tail, then at least one additional fiducial was placed in that location. The locations of the external fiducials were marked on the skin with indelible ink. The participant was imaged in the supine position with the arm on the affected side abducted, thereby emulating the ultrasound position. A plastic bridge was utilised to support a 32 channel phased array torso receiver coil (NeoCoil LLC, Pewaukee, WI, USA) and ensure that it did not deform the affected breast, but allowed the breast to fall into a natural position. Once three co-registration pairs were recorded the ultrasound system registered the MR and ultrasound and provided a quality measure (root mean square deviation, RMSD). If more than three co-registration points were identified the ultrasound system utilised the 3 co-registration point pairings that resulted in the lowest RMSD.
Once the MR and ultrasound images were registered the LOGIQ E9 system simultaneously reformatted the 3D MR dataset to match the position and orientation of the ultrasound image and applied the resulting registration matrix to the two remaining MR datasets. Since the registration matrix had been applied to all the MR datasets it was possible to switch between MR image types, while performing the real-time ultrasound, without repeating the co-registration process.
Following co-registration the RMSD was recorded. Additionally, both lesion and global co-registration accuracy was assessed. Lesion co-registration accuracy was determined by separately recording the centre of the lesion on both the real-time ultrasound image and on the MR dataset. Once the lesion centre had been recorded on both imaging modalities, the LOGIQ E9 system calculated the difference between the two points in 3D space thereby determining the accuracy. Global co-registration accuracy was determined qualitatively by the performing clinician using a five point scoring system (very poor -registration either does not match or only matches in a very limited area of the breast, poor -registration only matches over a limited portion of the breast, moderate -registration matches well but not globally over the whole breast, good -registration matches well globally over the whole breast, very goodregistration matches almost exactly globally over the whole breast).
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Once co-registration had been achieved the clinician was free to perform guide wire insertion either under rtMRnUS or purely under ultrasound guidance albeit with the cognitively retained MR information.
Results
Twenty-nine participants were recruited between November 2012 and March 2014.
To facilitate familiarisation with the co-registration process the first four cases were utilised as a training set. Consequently, the results of twenty-five participants with a median (min, max) age of 61 (48-72) years are presented. Twenty-eight lesions were identified with a median (min, max) histopathological diameter of 11mm (5mm, 19mm). Further participant and lesion characteristics are presented in Table 1 .
Following standard triple assessment all study participants were believed to have a Representative rtMRnUS images are presented in Fig. 1 and 2 .
Following rtMRnUS facilitated guide wire insertion and subsequent BCS, histopathology revealed positive margins in 4/25 (16%) participants, two with DCIS alone and two with both invasive and in-situ disease identified at the margin.
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Discussion
This study investigated the feasibility of using supine MR images for rtMRnUS mediated guide wire insertion, to facilitate surgical planning of BCS. Additionally, metrics of co-registration quality such as RMSD, lesion and global registration accuracy were assessed. Finally, initial clinical experience is discussed.
For this study co-registration accuracy as determined by RMSD resulted in a median (min. max.) error of 3.3mm (0.6mm, 8.8mm). Rizzatto [5] , Fausto [6] and co-workers reported co-registration accuracy from five healthy volunteers utilizing the same ultrasound system and co-registration methodology as this study. Based on five point-to-probe measurements (three external fiducials, the nipple and an internal mammary artery) a 'misalignment of about 0.5cm' [6] was reported. Rizzatto et al. [5] further reported that preliminary clinical experience in 41 patients resulted in good co-registration in 'almost all' cases.
Two reports by Nakano et al. [7, 8] reported the co-registration accuracy with reference to a lesion. The experimental set-up by Nakano and co-workers employed both an electromagnetic field and a transducer mounted electromagnetic sensor similar to this work. However, to allow co-registration of the two image modalities only the nipple was utilised as a co-registration reference point. In the first paper, Nakano et al.
[7] reported a 7mm difference between the US and MR image with reference to the index lesion. The later study [8] reported a mean 3D positioning error of 12.0mm (SD±7.5mm; range 2 to 40mm) between the US and MR lesion location from 63 tumours. The level of lesion co-registration accuracy was similar in our study to the reports by Nakano et al. [7, 8] with a median (min, max) lesion accuracy of 8.9mm (2.1mm, 33.2mm) from 25 lesions.
14 When considering the accuracy of co-registration for an organ such as the breast, it is important to realise that any quality metric assigned to that registration may not be appropriate to the whole breast. If one considers a hemisphere as a simplified representation of a breast, the pole of the hemisphere would represent the nipple and external fiducials would be placed in 12-, 3-, 6-, and 9-o'clock positions relative to the nipple. Even if the RMSD following co-registration is very low, it only represents the geometry relative to the co-registration pairs utilised in the registration process. Consequently, the registration quality distant to these co-registration pairs may be significantly poorer than the RMSD indicates. It is for this reason that in our methodology if the index lesion was known to be located at an extreme edge of the breast, such as the axillary tail, then at least one additional fiducial was placed in that location, in the hope that the registration geometry would encompass the area of the breast containing the index lesion. The study by Nakano et al. [8] , in which the nipple represented the registration reference point, investigated this problem by comparing the lesion accuracy from proximal tumours (<40mm distance to nipple) against distal lesions (≥40mm distance to nipple). A greater but non-significant difference was noted in lesion positional error for distal (13.7mm SD±8.6mm; range 5 to 39mm) compared to proximal (11.0mm SD±6.8mm; range 2 to 40mm) tumours.
In the current study "global" co-registration accuracy was assessed qualitatively by the performing clinician on a five point scoring system. Co-registration accuracy was assessed by comparing the location of prominent features such as nipple, parenchyma, internal mammary nodes and vasculature on both imaging modalities.
In three cases global accuracy was assessed as moderate and poor in a further two cases. However, the median (min, max) RMSD in these five cases was 4.1mm (2.9mm, 5.3mm), which was similar to the whole cohort at 3.3mm (0.6mm, 8.8mm).
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Consequently, it seems that while a co-registration quality metric is useful, the operator must consider its validity in relation to the lesion position relative to the coregistration pairs utilised in the registration process.
Our initial clinical experience indicates that transducer pressure and breast size are the main factors that impact on rtMRnUS co-registration accuracy. Transducer pressure will obviously affect not only the co-registration accuracy, but also image quality. During the co-registration process as little transducer pressure as possible is used to ensure the breast maintains a shape similar to that obtained at MR imaging. increased, the registration matrix will become invalid but the image quality will improve, and the ultrasound operator can interrogate tissue in that area of the breast. Frequently, this will reveal the abnormality. If the transducer pressure is reduced and the breast returns to its normal shape the initial registration matrix will be valid once more.
Unlike Fausto et al. [6] we did not exclude participants based on breast size and although not assessed formally we did note that larger breasts can be more difficult to co-register. Nevertheless, we were able to perform rtMRnUS in all cases.
Primarily, we believe that larger breasts can pose a co-registration challenge due to the greater range of deformation, both in terms of the position the breast naturally falls into when the patient is supine and in response to transducer pressure. By comparison smaller breasts have a smaller range of deformation.
The use of rtMRnUS seems to result in a number of benefits. Chang et al. [11] reported that rtMRnUS provided a more accurate estimation of breast tumour longest dimension than ultrasound alone, when compared to histopathology results.
Additionally, increased detection rates have been reported for rtMRnUS compared to one lesion demonstrated by triple assessment was identified by supine MR and three additional foci were also identified using this technique. Secondly, the small number of participants and single centre nature of this study means that the results might be the subject of bias. Thirdly, due to the study design researchers were aware that participants were scheduled for BCS and therefore must have at least one lesion present, this knowledge might also have introduced bias into the results.
In conclusion this study has demonstrated the accuracy of rtMRnUS following coregistration of breast MR and ultrasound data. Furthermore, we have reported initial clinical experience in the use of rtMRnUS in the surgical planning of BCS via guide wire insertion and demonstrated that it is a feasible technique. 
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